MedTrace Logo

A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil

NCT05155488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-05-09

No results posted yet for this study

Summary

The main aims of the study are to learn about the percentage of mucopolysaccharidosis type II (MPS II) in adults in Brazil as well as about the diagnosis process. No study medicines will be provided to participants in this study. The data available for participants diagnosed with MPS II in DATASUS (a database of the Informatics Department of Brazilian Health System) will be reviewed. No clinic visits will be required as part of participation in this study.

Conditions

  • Mucopolysaccharidosis (MPS)

Interventions

OTHER

No Intervention

This is a non-interventional study.

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-06
Primary Completion
2022-02-15
Completion
2022-02-15

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155488 on ClinicalTrials.gov